News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
636,722 Results
Type
Article (42726)
Company Profile (120)
Press Release (593876)
Multimedia
Podcasts (86)
Webinars (11)
Section
Business (187824)
Career Advice (2345)
Deals (31030)
Drug Delivery (82)
Drug Development (70534)
Employer Resources (126)
FDA (15614)
Job Trends (13559)
News (313320)
Policy (29940)
Tag
Academia (2449)
Academic (1)
Accelerated approval (5)
Adcomms (18)
Allergies (93)
Alliances (47199)
ALS (89)
Alzheimer's disease (1286)
Antibody-drug conjugate (ADC) (104)
Approvals (15642)
Artificial intelligence (258)
Autoimmune disease (21)
Automation (13)
Bankruptcy (287)
Best Places to Work (10619)
BIOSECURE Act (11)
Biosimilars (76)
Biotechnology (85)
Bladder cancer (73)
Brain cancer (24)
Breast cancer (276)
Cancer (2098)
Cardiovascular disease (167)
Career advice (1941)
Career pathing (26)
CAR-T (131)
Cell therapy (399)
Cervical cancer (21)
Clinical research (57864)
Collaboration (793)
Compensation (354)
Complete response letters (13)
COVID-19 (2268)
CRISPR (38)
C-suite (234)
Cystic fibrosis (76)
Data (2156)
Decentralized trials (2)
Denatured (33)
Depression (41)
Diabetes (252)
Diagnostics (5836)
Digital health (16)
Diversity (6)
Diversity, equity & inclusion (36)
Drug discovery (107)
Drug pricing (87)
Drug shortages (24)
Duchenne muscular dystrophy (87)
Earnings (78364)
Editorial (38)
Employer branding (17)
Employer resources (113)
Events (98400)
Executive appointments (697)
FDA (16926)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (682)
Gene editing (89)
Generative AI (22)
Gene therapy (284)
GLP-1 (654)
Government (4134)
Grass and pollen (6)
Guidances (147)
Healthcare (17651)
Huntington's disease (16)
IgA nephropathy (25)
Immunology and inflammation (93)
Indications (29)
Infectious disease (2393)
Inflammatory bowel disease (125)
Inflation Reduction Act (9)
Influenza (49)
Intellectual property (91)
Interviews (401)
IPO (14287)
IRA (35)
Job creations (3362)
Job search strategy (1676)
Kidney cancer (8)
Labor market (30)
Layoffs (362)
Leadership (18)
Legal (7179)
Liver cancer (72)
Lung cancer (295)
Lymphoma (143)
Machine learning (7)
Management (44)
Manufacturing (265)
MASH (69)
Medical device (13929)
Medtech (13933)
Mergers & acquisitions (17268)
Metabolic disorders (634)
Multiple sclerosis (71)
NASH (15)
Neurodegenerative disease (82)
Neuropsychiatric disorders (19)
Neuroscience (1779)
NextGen: Class of 2025 (6032)
Non-profit (4205)
Now hiring (19)
Obesity (324)
Opinion (193)
Ovarian cancer (70)
Pain (91)
Pancreatic cancer (78)
Parkinson's disease (140)
Partnered (20)
Patents (211)
Patient recruitment (108)
Peanut (48)
People (53507)
Pharmaceutical (30)
Pharmacy benefit managers (15)
Phase I (17519)
Phase II (25195)
Phase III (19664)
Pipeline (1250)
Policy (122)
Postmarket research (2464)
Preclinical (7237)
Press Release (69)
Prostate cancer (106)
Psychedelics (28)
Radiopharmaceuticals (234)
Rare diseases (322)
Real estate (5141)
Recruiting (47)
Regulatory (20613)
Reports (31)
Research institute (2213)
Resumes & cover letters (380)
Rett syndrome (5)
RNA editing (4)
RSV (35)
Schizophrenia (68)
Series A (116)
Series B (78)
Service/supplier (7)
Sickle cell disease (46)
Special edition (12)
Spinal muscular atrophy (130)
Sponsored (26)
Startups (3094)
State (1)
Stomach cancer (12)
Supply chain (53)
Tariffs (33)
The Weekly (52)
Vaccines (597)
Venture capitalists (25)
Weight loss (214)
Women's health (27)
Worklife (13)
Date
Today (30)
Last 7 days (855)
Last 30 days (2715)
Last 365 days (29281)
2025 (10675)
2024 (31785)
2023 (36172)
2022 (46812)
2021 (50697)
2020 (49594)
2019 (43183)
2018 (32836)
2017 (30113)
2016 (29469)
2015 (34650)
2014 (28397)
2013 (24445)
2012 (25815)
2011 (26075)
2010 (24747)
Location
Africa (819)
Alabama (51)
Alaska (5)
Arizona (174)
Arkansas (11)
Asia (37452)
Australia (6191)
California (5544)
Canada (1873)
China (498)
Colorado (248)
Connecticut (263)
Delaware (151)
Europe (83236)
Florida (859)
Georgia (198)
Idaho (54)
Illinois (521)
India (25)
Indiana (300)
Iowa (7)
Japan (167)
Kansas (96)
Kentucky (23)
Louisiana (10)
Maine (68)
Maryland (864)
Massachusetts (4046)
Michigan (221)
Minnesota (385)
Mississippi (2)
Missouri (71)
Montana (29)
Nebraska (24)
Nevada (63)
New Hampshire (66)
New Jersey (1658)
New Mexico (19)
New York (1622)
North Carolina (932)
North Dakota (8)
Northern California (2470)
Ohio (187)
Oklahoma (11)
Oregon (31)
Pennsylvania (1302)
Puerto Rico (10)
Rhode Island (31)
South America (1146)
South Carolina (25)
Southern California (2101)
Tennessee (100)
Texas (856)
United States (21375)
Utah (180)
Virginia (141)
Washington D.C. (61)
Washington State (478)
West Virginia (3)
Wisconsin (57)
636,722 Results for "a and e medical corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spectral Medical Announces First Quarter and Provides Corporate Update
May 9, 2025
·
13 min read
Vaccines
Sanofi Hit With $250M Impairment After Scrapping J&J-Partnered
E. coli
Vaccine
Without providing specific data, Sanofi on Thursday announced that the experimental vaccine did not significantly prevent invasive
E. coli
disease versus placebo.
February 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Apyx Medical Corporation Reports First Quarter 2025 Financial Results
May 9, 2025
·
15 min read
Press Releases
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
March 26, 2025
·
17 min read
Press Releases
Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round
January 15, 2025
·
3 min read
Press Releases
CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer
May 7, 2025
·
3 min read
Press Releases
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
April 1, 2025
·
6 min read
Business
Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
Daxor Corporation today announces the appointment of Dr. John L. Jefferies, M.D., M.B.A., M.P.H., F.A.C.C., F.A.H.A., F.A.A.P., F.H.F.S.A., F.E.S.C., F.R.C.P.E., as Chief Medical Officer.
June 5, 2024
·
4 min read
Press Releases
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
May 8, 2025
·
2 min read
Press Releases
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
April 24, 2025
·
1 min read
1 of 63,673
Next
